Failure of plasma brain natriuretic peptide to identify left ventricular systolic dysfunction in the community

被引:31
|
作者
Hetmanski, DJ [1 ]
Sparrow, NJ [1 ]
Curtis, S [1 ]
Cowley, AJ [1 ]
机构
[1] Univ Nottingham Hosp, Ctr Continuing Postgrad Med Educ, Nottingham NG7 2UH, England
关键词
D O I
10.1136/heart.84.4.440
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:440 / 441
页数:2
相关论文
共 50 条
  • [21] Plasma brain natriuretic peptide concentration as a prognostic predictor in patients with symptomatic left ventricular dysfunction
    Tsutamoto, T
    Maeda, K
    Wada, A
    Hisanaga, T
    Maeda, Y
    Fukai, D
    Ohnishi, M
    Sugimoto, Y
    Kinoshita, M
    CIRCULATION, 1996, 94 (08) : 1490 - 1490
  • [22] Brain natriuretic peptide and systolic or isolated diastolic heart failure in the community
    Bursi, F
    Redfield, MM
    Weston, SA
    Jacobsen, SJ
    Pakhomov, S
    Nkomo, VI
    Meverden, RA
    Roger, VL
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 48A - 48A
  • [23] Plasma concentrations of n-terminal-pro brain natriuretic peptide in patients with suspected heart failure but preserved left ventricular systolic dysfunction: data from the EuroHeart Failure Survey
    Cleland, JGF
    Hanning, I
    EUROPEAN HEART JOURNAL, 2004, 25 : 286 - 287
  • [24] Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy
    Yamamoto, K
    Burnett, JC
    Jougasaki, M
    Nishimura, RA
    Bailey, KR
    Saito, Y
    Nakao, K
    Redfield, MM
    HYPERTENSION, 1996, 28 (06) : 988 - 994
  • [25] The use at N-terminal atrial natriuretic peptide and brain natriuretic peptide to detect the presence of left ventricular systolic dysfunction: a population based study
    Robb, SD
    McDonagh, TA
    Morton, JJ
    Morrison, CE
    Dargie, HJ
    EUROPEAN HEART JOURNAL, 2000, 21 : 134 - 134
  • [26] The use of N-terminal atrial natriuretic peptide and brain natriuretic peptide to detect the presence of left ventricular systolic dysfunction: A population based study
    Robb, SD
    McDonagh, TA
    Morrison, CE
    Dargie, HJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) : 180A - 181A
  • [27] Usefulness of plasma brain-type natriuretic peptide level to differentiate left ventricular diastolic dysfunction from preserved diastolic function in patients with systolic dysfunction
    Goto, T
    Ohte, N
    Miyabe, H
    Sakata, S
    Asada, K
    Mukai, S
    Hayano, J
    Kimura, G
    AMERICAN JOURNAL OF CARDIOLOGY, 2005, 95 (11): : 1383 - 1385
  • [28] Characteristics of the increase in plasma brain natriuretic peptide level in left ventricular systolic dysfunction, associated with muscular dystrophy in comparison with idiopathic dilated cardiomyopathy
    Demachi, J
    Kagaya, Y
    Watanabe, J
    Sakuma, M
    Ikeda, J
    Kakuta, Y
    Motoyoshi, I
    Kohnosu, T
    Sakuma, H
    Shimazaki, S
    Sakai, H
    Kimpara, T
    Takahashi, T
    Omura, K
    Okada, M
    Saito, H
    Shirato, K
    NEUROMUSCULAR DISORDERS, 2004, 14 (11) : 732 - 739
  • [29] Brain natriuretic peptide facilitates severity classification of stable chronic heart failure with left ventricular dysfunction
    Sakurai, S
    Adachi, H
    Hasegawa, A
    Hoshizaki, H
    Oshima, S
    Taniguchi, K
    Kurabayashi, M
    HEART, 2003, 89 (06) : 661 - 662
  • [30] Reduced myocardial velocities of left ventricular long-axis contraction identify both systolic and diastolic heart failure - a comparison with brain natriuretic peptide
    Vinereanu, D
    Lim, PO
    Frenneaux, MP
    Fraser, AG
    EUROPEAN JOURNAL OF HEART FAILURE, 2005, 7 (04) : 512 - 519